WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 8 fonti

Why drugs like Ozempic might reduce cancer risk

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

Raccontata da

independent.co.uk

scientificamerican.com

oglobo.globo.com

medpagetoday.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

scientificamerican.comStai leggendo19 h fa

Why drugs like Ozempic might reduce cancer risk

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

Timeline cronologica

sabato 6 giugno 2026·fanpage.it
Ozempic e farmaci dimagranti, rischio di tumore al seno più basso del 30%: i risultati all’ASCO 2026
Un nuovo studio presentato all'ASCO su oltre 110.000 donne rileva che chi assume farmaci GLP-1 come Ozempic e Wegovy sviluppa il tumore al seno con una
domenica 7 giugno 2026·latercera.com
Nuevos estudios muestran que las inyecciones para bajar de peso tienen beneficios en el cáncer y la menopausia - La Tercera
Una serie de nuevas investigaciones muestran que los fármacos GLP-1, como Ozempic, Wegovy y Mounjaro, podrían tener efectos positivos sobre el cáncer y mejorar los síntomas de la…

2 g fa

Ozempic e farmaci dimagranti, rischio di tumore al seno più basso del 30%: i risultati all’ASCO 2026

Un nuovo studio presentato all'ASCO su oltre 110.000 donne rileva che chi assume farmaci GLP-1 come Ozempic e Wegovy sviluppa il tumore al seno con una

Leggi questa versione → originale

afr.com11 h fa

Here’s how GLP-1 drugs could save your life, as well as make you slim

GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.

Leggi questa versione → originale

latercera.com1 g fa

Nuevos estudios muestran que las inyecciones para bajar de peso tienen beneficios en el cáncer y la…

Una serie de nuevas investigaciones muestran que los fármacos GLP-1, como Ozempic, Wegovy y Mounjaro, podrían tener efectos positivos sobre el cáncer y mejorar los síntomas de la menopausia.

Leggi questa versione → originale

independent.co.uk23 h fa

Weight loss jabs linked to dramatic fall in obesity cancer risk

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be…

Leggi questa versione → originale

mirror.co.uk1 g fa

Weight loss jabs 'should be probed as cancer prevention agents' after US study

Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about cancer prevention"

Leggi questa versione → originale

lunedì 8 giugno 2026·

mirror.co.uk

Weight loss jabs 'should be probed as cancer prevention agents' after US study

Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about…

lunedì 8 giugno 2026·

independent.co.uk

Weight loss jabs linked to dramatic fall in obesity cancer risk

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

lunedì 8 giugno 2026·

scientificamerican.com

Why drugs like Ozempic might reduce cancer risk

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

lunedì 8 giugno 2026·

oglobo.globo.com

Canetas emagrecedoras reduzem em 41% o risco de cânceres ligados à obesidade, diz novo estudo

Trabalho analisou dados de milhares de pacientes que receberam Ozempic, Wegovy e Mounjaro ao longo de dois anos

lunedì 8 giugno 2026·

medpagetoday.com

Large Study Links GLP-1s to Lower Risk of Multiple Cancers

Patients taking the drugs for obesity had a 41% lower risk of related cancers

lunedì 8 giugno 2026·

afr.com

Here’s how GLP-1 drugs could save your life, as well as make you slim

GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.